Literature DB >> 19188162

Ionizing radiation up-regulates telomerase activity in cancer cell lines by post-translational mechanism via ras/phosphatidylinositol 3-kinase/Akt pathway.

Ron Ram1, Orit Uziel, Orit Eldan, Eyal Fenig, Einat Beery, Shelly Lichtenberg, Yardena Nordenberg, Meir Lahav.   

Abstract

PURPOSE: Telomerase is considered currently as a hallmark of cancer, and its inhibition is expected to become an important anticancer modality. In contrast to abundant data concerning the effect of cytotoxic drugs on telomerase activity (TA), there is scant information on the effect of radiation on telomerase. The mechanism of telomerase regulation by irradiation has never been evaluated in detail. In the present study, we investigated the effect of radiation on TA and its regulation in cancer cells. EXPERIMENTAL
DESIGN: The effect of various radiation doses on TA in several malignant and nonmalignant cell lines was evaluated. All malignant cells exhibited similar telomerase response to radiation and its regulation was assessed at transcriptional and post-translational levels in K562 cells. Next step was the evaluation of the upstream signaling pathways leading to changes in TA using kinetics and specific inhibitors.
RESULTS: Radiation up-regulated TA in dose-dependent manner only in cancer cells. Telomerase was activated by phosphorylation by Akt and by cytoplasmic-nuclear shift. Transcriptional processes were not involved in TA. This telomerase regulation is mediated by Ras/phosphatidylinositol 3-kinase/Akt pathway. The canonical membrane effectors of irradiation (epidermal growth factor receptor, insulin-like growth factor-I receptor, and Ca2+ influx) were not involved in this process.
CONCLUSIONS: Radiation up-regulates telomerase activity specifically in cancer cells. This study adds to accumulating evidence pointing to post-translational level as important mode of telomerase regulation. Telomerase activation due to radiation may be detrimental in treatment of cancer. Data described in this study may add to future interventions aiming at inhibition of telomerase activation during irradiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188162     DOI: 10.1158/1078-0432.CCR-08-0792

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

1.  Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.

Authors:  Jau-Yu Liau; Jen-Chieh Lee; Jia-Huei Tsai; Ching-Yao Yang; Tsung-Lin Liu; Zhi-Long Ke; Hung-Han Hsu; Yung-Ming Jeng
Journal:  Mod Pathol       Date:  2015-10-02       Impact factor: 7.842

Review 2.  Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.

Authors:  Grace Shim; Michelle Ricoul; William M Hempel; Edouard I Azzam; Laure Sabatier
Journal:  Mutat Res Rev Mutat Res       Date:  2014-01-31       Impact factor: 5.657

3.  Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.

Authors:  Orit Uziel; Einat Beery; Vladimir Dronichev; Katty Samocha; Sergei Gryaznov; Lola Weiss; Shimon Slavin; Michal Kushnir; Yardena Nordenberg; Claudette Rabinowitz; Baruch Rinkevich; Tania Zehavi; Meir Lahav
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

4.  Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.

Authors:  Kathleen Dorris; Matthew Sobo; Arzu Onar-Thomas; Eshini Panditharatna; Charles B Stevenson; Sharon L Gardner; Mariko D Dewire; Christopher R Pierson; Randal Olshefski; Sandra A Rempel; Stewart Goldman; Lili Miles; Maryam Fouladi; Rachid Drissi
Journal:  J Neurooncol       Date:  2014-01-30       Impact factor: 4.130

5.  Telomere lengthening and other functions of telomerase.

Authors:  M P Rubtsova; D P Vasilkova; A N Malyavko; Yu V Naraikina; M I Zvereva; O A Dontsova
Journal:  Acta Naturae       Date:  2012-04       Impact factor: 1.845

6.  Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment.

Authors:  Roland Nassim; Jose Joao Mansure; Simone Chevalier; Fabio Cury; Wassim Kassouf
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

7.  Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.

Authors:  C Weiss; O Uziel; O Wolach; J Nordenberg; E Beery; S Bulvick; G Kanfer; O Cohen; R Ram; M Bakhanashvili; H Magen-Nativ; N Shilo; M Lahav
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

8.  The emerging role of telomerase reverse transcriptase in mitochondrial DNA metabolism.

Authors:  Donna M Gordon; Janine Hertzog Santos
Journal:  J Nucleic Acids       Date:  2010-09-21

9.  Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells.

Authors:  Nitin Koul; Vivek Sharma; Deobrat Dixit; Sadashib Ghosh; Ellora Sen
Journal:  BMC Cancer       Date:  2010-06-24       Impact factor: 4.430

Review 10.  Human telomerase activity regulation.

Authors:  Aneta Wojtyla; Marta Gladych; Blazej Rubis
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.